Izzo AA and Sharkey KA |
Cannabinoids and the gut: new developments and emerging concepts. |
2010 |
Pharmacol. Ther. |
pmid:20117132
|
Porter AC and Felder CC |
The endocannabinoid nervous system: unique opportunities for therapeutic intervention. |
2001 |
Pharmacol. Ther. |
pmid:11448725
|
Woodward DF et al. |
The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. |
2008 |
Pharmacol. Ther. |
pmid:18700152
|
McFarland MJ and Barker EL |
Anandamide transport. |
2004 |
Pharmacol. Ther. |
pmid:15518883
|
Goutopoulos A and Makriyannis A |
From cannabis to cannabinergics: new therapeutic opportunities. |
2002 |
Pharmacol. Ther. |
pmid:12182958
|
Hansen HS et al. |
Putative neuroprotective actions of N-acyl-ethanolamines. |
2002 |
Pharmacol. Ther. |
pmid:12182959
|
Randall MD et al. |
Cardiovascular effects of cannabinoids. |
2002 |
Pharmacol. Ther. |
pmid:12182966
|
Snider NT et al. |
Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. |
2010 |
Pharmacol. Rev. |
pmid:20133390
|
Blankman JL and Cravatt BF |
Chemical probes of endocannabinoid metabolism. |
2013 |
Pharmacol. Rev. |
pmid:23512546
|
Mulè F et al. |
Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. |
2007 |
Pharmacol. Res. |
pmid:17574859
|
Khasabova IA et al. |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. |
2014 |
Pharmacol. Res. |
pmid:25304184
|
Mulè F et al. |
Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. |
2007 |
Pharmacol. Res. |
pmid:17656103
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Kerr DM et al. |
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. |
2016 |
Pharmacol. Res. |
pmid:27592249
|
Yousif MH and Oriowo MA |
Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. |
1999 |
Pharmacol. Res. |
pmid:10527656
|
Spradley JM et al. |
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. |
2010 |
Pharmacol. Res. |
pmid:20416378
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
De Petrocellis L et al. |
N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity. |
2011 |
Pharmacol. Res. |
pmid:21215315
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Malek N et al. |
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. |
2016 |
Pharmacol. Res. |
pmid:27326920
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Maione S et al. |
Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. |
2013 |
Pharmacol. Res. |
pmid:23911581
|
Khasabova IA et al. |
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. |
2011 |
Pharmacol. Res. |
pmid:21440630
|
Baranowska-Kuczko M et al. |
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. |
2012 |
Pharmacol. Res. |
pmid:22627170
|
Fowler CJ et al. |
The endocannabinoid signaling system: pharmacological and therapeutic aspects. |
2005 |
Pharmacol. Biochem. Behav. |
pmid:15935456
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Wiley JL |
Cannabis: discrimination of "internal bliss"? |
1999 |
Pharmacol. Biochem. Behav. |
pmid:10515300
|
Romero J et al. |
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. |
1995 |
Pharmacol. Biochem. Behav. |
pmid:7675852
|
Wiley JL and Burston JJ |
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats. |
2010 |
Pharmacol. Biochem. Behav. |
pmid:19941884
|
Herrera-SolÃs A et al. |
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. |
2010 |
Pharmacol. Biochem. Behav. |
pmid:20056119
|
Rawls SM et al. |
Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats. |
2006 |
Pharmacol. Biochem. Behav. |
pmid:16647109
|
Crawley JN et al. |
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. |
1993 |
Pharmacol. Biochem. Behav. |
pmid:7906042
|
Wiley JL et al. |
Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9408225
|
Wenger T et al. |
The effects of prenatally administered endogenous cannabinoid on rat offspring. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9300616
|
Reyes-Cabello C et al. |
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. |
2012 |
Pharmacol. Biochem. Behav. |
pmid:22133635
|
Tuboly G et al. |
The antinociceptive interaction of anandamide and adenosine at the spinal level. |
2009 |
Pharmacol. Biochem. Behav. |
pmid:18760296
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Sadhasivam S et al. |
Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. |
2015 |
Pharmacogenomics J. |
pmid:25558980
|
Laine K et al. |
Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. |
2001 |
Pharm. Res. |
pmid:11451037
|
Pate DW et al. |
Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. |
1997 |
Pharm. Res. |
pmid:9453062
|
Krishtal O et al. |
The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids. |
2006 |
Pflugers Arch. |
pmid:16741755
|
Kenessey I et al. |
Revisiting CB1 receptor as drug target in human melanoma. |
2012 |
Pathol. Oncol. Res. |
pmid:22447182
|
Farquhar-Smith WP et al. |
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. |
2002 |
Pain |
pmid:12031775
|
Horvath G et al. |
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. |
2008 |
Pain |
pmid:17533116
|
Lichtman AH et al. |
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. |
2004 |
Pain |
pmid:15157693
|
Guindon J et al. |
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. |
2006 |
Pain |
pmid:16480822
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Butler RK et al. |
Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. |
2008 |
Pain |
pmid:19004548
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|